• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Early corticosteroid treatment for severe pneumonia caused by 2009 H1N1 influenza virus.2009年甲型H1N1流感病毒所致重症肺炎的早期糖皮质激素治疗
Crit Care. 2011;15(2):413. doi: 10.1186/cc10082. Epub 2011 Mar 22.
2
Influenza A/H1N1 2009 pneumonia in kidney transplant recipients: characteristics and outcomes following high-dose oseltamivir exposure.2009年甲型H1N1流感肺炎在肾移植受者中的情况：大剂量使用奥司他韦后的特征及转归
Transpl Infect Dis. 2010 Apr;12(2):127-31. doi: 10.1111/j.1399-3062.2010.00493.x. Epub 2010 Jan 20.
3
Thrombotic thrombocytopenic purpura triggered by influenza A virus subtype H1N1 infection.甲型H1N1流感病毒感染引发的血栓性血小板减少性紫癜
Transfus Apher Sci. 2012 Feb;46(1):25-8. doi: 10.1016/j.transci.2011.10.024. Epub 2011 Nov 16.
4
Antiviral treatment and virological monitoring of oseltamivir-resistant influenza virus A(H1N1)pdm09 in a patient with chronic B lymphocytic leukemia.慢性 B 淋巴细胞白血病患者中奥司他韦耐药的甲型 H1N1pdm09 流感病毒的抗病毒治疗和病毒学监测。
J Infect Chemother. 2019 Jul;25(7):543-546. doi: 10.1016/j.jiac.2018.11.008. Epub 2019 Apr 20.
5
High-dose N-acetylcysteine therapy for novel H1N1 influenza pneumonia.高剂量N-乙酰半胱氨酸治疗新型H1N1流感肺炎。
Ann Intern Med. 2010 May 18;152(10):687-8. doi: 10.7326/0003-4819-152-10-201005180-00017.
6
[Case of novel influenza A (H1N1) encephalopathy with transient low TSH level].[新型甲型H1N1流感脑病伴短暂促甲状腺激素水平降低病例]
No To Hattatsu. 2010 Sep;42(5):377-9.
7
Methylprednisolone infusion for life-threatening H1N1-virus infection.甲泼尼龙输注液治疗危及生命的 H1N1 病毒感染。
Ther Adv Respir Dis. 2010 Aug;4(4):233-7. doi: 10.1177/1753465810376951. Epub 2010 Jul 16.
8
[Etiotropic therapy of influenza: lessons from the last pandemic].[流感的病因特异性治疗：上一次大流行的经验教训]
Vestn Ross Akad Med Nauk. 2011(5):35-40.
9
Reducing occurrence and severity of pneumonia due to pandemic H1N1 2009 by early oseltamivir administration: a retrospective study in Mexico.通过早期奥司他韦给药减少大流行 H1N1 2009 引起的肺炎的发生和严重程度：墨西哥的一项回顾性研究。
PLoS One. 2011;6(7):e21838. doi: 10.1371/journal.pone.0021838. Epub 2011 Jul 8.
10
Corticosteroids do not cause harmful increase of viral load in severe H1N1 virus infection.在严重的H1N1病毒感染中，皮质类固醇不会导致病毒载量出现有害增加。
Intensive Care Med. 2010 Oct;36(10):1780-1781. doi: 10.1007/s00134-010-1964-8. Epub 2010 Jul 15.

引用本文的文献

1
Beneficial effect of sequential treatment with high-dose steroids and short-course oral glucocorticoids in patients with severe influenza virus-associated pneumonia.大剂量类固醇序贯治疗联合短程口服糖皮质激素治疗重症流感病毒相关性肺炎的疗效。
Sci Rep. 2024 Oct 23;14(1):25023. doi: 10.1038/s41598-024-76400-2.
2
Preliminary study regarding the predicted body weight-based dexamethasone therapy in patients with COVID-19 pneumonia.关于 COVID-19 肺炎患者基于预测体重的地塞米松治疗的初步研究。
Pulm Pharmacol Ther. 2022 Feb;72:102108. doi: 10.1016/j.pupt.2021.102108. Epub 2021 Dec 17.
3
Etiological and pathophysiological enigmas of severe coronavirus disease 2019, multisystem inflammatory syndrome in children, and Kawasaki disease.2019年冠状病毒病重症、儿童多系统炎症综合征及川崎病的病因学和病理生理学谜团
Clin Exp Pediatr. 2022 Apr;65(4):153-166. doi: 10.3345/cep.2021.01270. Epub 2021 Nov 23.
4
No clinical benefit of high dose corticosteroid administration in patients with COVID-19: A preliminary report of a randomized clinical trial.COVID-19 患者大剂量皮质类固醇给药没有临床获益：一项随机临床试验的初步报告。
Eur J Pharmacol. 2021 Apr 15;897:173947. doi: 10.1016/j.ejphar.2021.173947. Epub 2021 Feb 16.
5
Exploring an Integrative Therapy for Treating COVID-19: A Randomized Controlled Trial.探索一种治疗 COVID-19 的综合疗法：一项随机对照试验。
Chin J Integr Med. 2020 Sep;26(9):648-655. doi: 10.1007/s11655-020-3426-7. Epub 2020 Jul 16.
6
Immunopathogenesis of COVID-19 and early immunomodulators.新型冠状病毒肺炎的免疫发病机制及早期免疫调节剂
Clin Exp Pediatr. 2020 Jul;63(7):239-250. doi: 10.3345/cep.2020.00759. Epub 2020 Jun 18.
7
Recommendations for detection, prioritization, and treatment of thoracic oncology patients during the COVID-19 pandemic: the THOCOoP cooperative group.COVID-19 大流行期间胸部肿瘤患者的检测、优先排序和治疗建议：THOCOoP 合作组。
Crit Rev Oncol Hematol. 2020 Sep;153:103033. doi: 10.1016/j.critrevonc.2020.103033. Epub 2020 Jun 20.
8
Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease.分析与 2019 年新型冠状病毒病住院患者疾病结局相关的因素。
Chin Med J (Engl). 2020 May 5;133(9):1032-1038. doi: 10.1097/CM9.0000000000000775.
9
Early Corticosteroid Therapy for Pneumonia Irrespective of Used Antibiotics in Children.无论儿童肺炎使用何种抗生素，早期使用皮质类固醇治疗。
J Clin Med. 2019 May 22;8(5):726. doi: 10.3390/jcm8050726.
10
Corticosteroid treatment in critically ill patients with severe influenza pneumonia: a propensity score matching study.重症流感肺炎患者的皮质类固醇治疗：一项倾向评分匹配研究。
Intensive Care Med. 2018 Sep;44(9):1470-1482. doi: 10.1007/s00134-018-5332-4. Epub 2018 Aug 3.

本文引用的文献

1
Steroid-sensitive post-viral inflammatory pneumonitis (PVIP).类固醇敏感性病毒后炎症性肺炎（PVIP）
Am J Respir Crit Care Med. 2010 Oct 15;182(8):1089-90. doi: 10.1164/ajrccm.182.8.1089a.
2
Hyperactive immune cells (T cells) may be responsible for acute lung injury in influenza virus infections: a need for early immune-modulators for severe cases.过度活跃的免疫细胞（T 细胞）可能是流感病毒感染导致急性肺损伤的原因：严重病例需要早期免疫调节剂。
Med Hypotheses. 2011 Jan;76(1):64-9. doi: 10.1016/j.mehy.2010.08.032. Epub 2010 Sep 6.
3
Methylprednisolone infusion for life-threatening H1N1-virus infection.甲泼尼龙输注液治疗危及生命的 H1N1 病毒感染。
Ther Adv Respir Dis. 2010 Aug;4(4):233-7. doi: 10.1177/1753465810376951. Epub 2010 Jul 16.
4
H1N1 influenza A virus-associated acute lung injury: response to combination oseltamivir and prolonged corticosteroid treatment.甲型 H1N1 流感病毒相关性急性肺损伤：奥司他韦联合长期皮质类固醇治疗的反应。
Intensive Care Med. 2010 Jan;36(1):33-41. doi: 10.1007/s00134-009-1727-6. Epub 2009 Nov 19.

Early corticosteroid treatment for severe pneumonia caused by 2009 H1N1 influenza virus.

作者信息

Kil Hong-Ryang, Lee Jae-Ho, Lee Kyung-Yil, Rhim Jung-Woo, Youn You-Sook, Kang Jin-Han

出版信息

Crit Care. 2011;15(2):413. doi: 10.1186/cc10082. Epub 2011 Mar 22.

DOI:10.1186/cc10082
PMID:21457512
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3219342/
Abstract
摘要